| Literature DB >> 35883635 |
Enrica Urciuoli1, Barbara Peruzzi1.
Abstract
The nuclear lamina is a complex meshwork of intermediate filaments (lamins) that is located beneath the inner nuclear membrane and the surrounding nucleoplasm. The lamins exert both structural and functional roles in the nucleus and, by interacting with several nuclear proteins, are involved in a wide range of nuclear and cellular activities. Due their pivotal roles in basic cellular processes, lamin gene mutations, or modulations in lamin expression, are often associated with pathological conditions, ranging from rare genetic diseases, such as laminopathies, to cancer. Although a substantial amount of literature describes the effects that are mediated by the deregulation of nuclear lamins, some apparently controversial results have been reported, which may appear to conflict with each other. In this context, we herein provide our explanation of such "controversy", which, in our opinion, derives from the tissue-specific expression of nuclear lamins and their close correlation with mechanotransduction processes, which could be very different, or even opposite, depending on the specific mechanical conditions that should not be compared (a tissue vs. another tissue, in vivo studies vs. cell cultures on glass/plastic supports, etc.). Moreover, we have stressed the relevance of considering and reproducing the "mechano-environment" in in vitro experimentation. Indeed, when primary cells that are collected from patients or donors are maintained in a culture, the mechanical signals deriving from canonical experimental procedures of cell culturing could alter the lamin expression, thereby profoundly modifying the assessed cell type, in some cases even too much, compared to the cell of origin.Entities:
Keywords: cancer; in vitro experimentation; lamins; stiffness; tissue mechanobiology
Mesh:
Substances:
Year: 2022 PMID: 35883635 PMCID: PMC9318957 DOI: 10.3390/cells11142194
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 7.666
Lamin expression in primary cancer tissues and in cancer cell lines. Referring to the text, for each cancer type we have specified the samples assessed in the relative work, the basal lamin expression, and how in vitro modification of lamin expression impacts the tumoral behavior of cancer cell lines. ↑ = increase. ↓ = decrease.
| Cancer Type | Samples | Basal Lamin Expression | In Vitro Modification (Cancer Cell Lines) | Effects on Cells | Ref |
|---|---|---|---|---|---|
|
| Normal colonic | Lamin A expressed in the |
|
| [ |
| Cancer tissue | Worse prognosis for |
|
| ||
| SW480 cell line | Lamin A/C | Over-expression | ↑ cell motility | ||
|
| Primary surgical | [ | |||
| U87-MG and U251 | A- and B-type | Silencing of | ↓ growth and cell mobility | ||
|
| Primary GBM | Expression of | [ | ||
| T98G GBM | Moderate expression of | Over-expression of | ↑ cell aggressiveness | ||
| Silencing of | ↓ cell aggressiveness | ||||
|
| Benign and | High lamin A/C in benign glands; | [ | ||
| PC3, DU145, and LNCaP PC cell lines | Lamin A/C detected | Over-expression of | ↑ cell growth and | ||
| Silencing of | ↓ cell growth and | ||||
|
| Biopsies | ||||
| SH-SY5Y cell line | High Lamin A/C | ↑ cell motility and | |||
|
| Normal breast and cancer | High levels of A-type lamin in | [ | ||
|
| Ovarian cancer | High expression of lamin-A | [ | ||
| High-metastatic | Lamin A/C | Over-expression of | ↓ cell migration | ||
| Silencing of | ↑ cell migration | ||||
|
| Specimens from | Lamin A/C expression positively | [ | ||
| Normal human | Lamin A/C expression | Silencing of | ↑ cell proliferation | ||
| Over-expression of | ↓ tumor aggressiveness | ||||
|
| Primary tumors | Inverse correlation between | [ | ||
| TC-61 and A-673 | Higher Lamin A/C | Silencing of | ↑ cell aggressiveness | ||
| Over-expression of | ↓ motility, migration, |